Type
Business expansion
Country
France
Region
Bassin Parisien; Centre; Indre-et-Loire
Location of affected unit(s)
Monts
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

100 jobs
Number of planned job creations
Job creation
Announcement Date
11 March 2022
Employment effect (start)
11 March 2022
Foreseen end date
31 December 2022

Description

The Swedish group Recipharm has announced the recruitment of 100 people at its plant in Monts (Indre-et-Loire). New positions will be on permanent and fixed-term contracts (generally for more than 6 months). The site produces Moderna's COVID-19 vaccine in bottles and will install a fifth production line. In 2021, the state invested €35 million in the plant, as part of the recovery plan program. Two recruitment days are planned at the plant: on April 7 and May 7. The 5th line should be operational in July.

Headquartered in Stockholm, Recipharm is a leading contract development and manufacturing organisation (CDMO) in the pharmaceutical sector. It currently employs nearly 300 people in France.


Sources

Citation

Eurofound (2022), Recipharm, Business expansion in France, factsheet number 106572, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/106572.